![Matthew Onaitis](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Matthew Onaitis
Director of Finance/CFO at
MAINSTAY MEDICAL INTERNATIONAL
Profile
Matthew W.
Onaitis is currently Director at Snp Bio, Inc. and Stratify Genomics, Inc. He serves as Chief Financial Officer at Mainstay Medical International Ltd. since 2018 and at Mainstay Medical Holdings Plc.
Formerly, Mr. Onaitis was Director-Legal Affairs at Elan Corp.
Plc from 2004 to 2005, Associate General Counsel at Biogen, Inc. in 2006, Secretary, Senior Vice President & General Counsel at Somaxon Pharmaceuticals, Inc. from 2010 to 2013, Secretary & General Counsel at Trius Therapeutics, Inc. in 2013, Secretary & General Counsel at Ignyta, Inc. from 2014 to 2016, and CFO, Secretary, CAO & General Counsel at Cidara Therapeutics, Inc. in 2018.
Education includes an undergraduate degree from Carnegie Mellon University in 1993 and a graduate degree from Stanford Law School in 1998.
Matthew Onaitis active positions
| Companies | Position | Start |
|---|---|---|
| MAINSTAY MEDICAL INTERNATIONAL | Director of Finance/CFO | 20/08/2018 |
Snp Bio, Inc. | Director/Board Member | - |
Stratify Genomics, Inc.
 Stratify Genomics, Inc. Medical/Nursing ServicesHealth Services Operates as a cancer risk stratification company | Director/Board Member | - |
Mainstay Medical Holdings Plc
 Mainstay Medical Holdings Plc Financial ConglomeratesFinance Functions as an investment holding company | Director of Finance/CFO | - |
Former positions of Matthew Onaitis
| Companies | Position | End |
|---|---|---|
| CIDARA THERAPEUTICS | Director of Finance/CFO | 17/08/2018 |
| IGNYTA INC | General Counsel | 01/06/2016 |
Trius Therapeutics, Inc.
 Trius Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops antibacterial drugs for the treatment of infections | General Counsel | 01/12/2013 |
Somaxon Pharmaceuticals, Inc.
 Somaxon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products | General Counsel | 01/03/2013 |
| BIOGEN INC. | Corporate Officer/Principal | 01/05/2006 |
Training of Matthew Onaitis
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
77
1st degree connections
12
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 12 |
|---|---|
Elan Corp. Plc
 Elan Corp. Plc Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals and drug delivery systems | Health Technology |
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Carnegie Mellon University
 Carnegie Mellon University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Somaxon Pharmaceuticals, Inc.
Somaxon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products | Health Technology |
Mainstay Medical International Ltd.
 Mainstay Medical International Ltd. Medical SpecialtiesHealth Technology Operates as a medical device company, which is engaged in the development of neurostimulation therapies for the population of people with debilitating chronic low back pain | Health Technology |
Trius Therapeutics, Inc.
Trius Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops antibacterial drugs for the treatment of infections | Health Technology |
Ignyta, Inc.
 Ignyta, Inc. BiotechnologyHealth Technology Operates as a medicine biotechnology company which provides new drugs services for cancer patients | Health Technology |
Stanford Law School
 Stanford Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cidara Therapeutics, Inc.
 Cidara Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Engages in the discovery, development, and commercialization of novel anti-infectives | Health Technology |
Snp Bio, Inc. | |
Stratify Genomics, Inc.
Stratify Genomics, Inc. Medical/Nursing ServicesHealth Services Operates as a cancer risk stratification company | Health Services |
Mainstay Medical Holdings Plc
Mainstay Medical Holdings Plc Financial ConglomeratesFinance Functions as an investment holding company | Finance |
- Stock Market
- Insiders
- Matthew Onaitis
